Q&A: Survey reveals unmet needs in IBS symptom management, treatment
Nearly half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported it was more challenging to manage their irritable bowel syndrome and chronic idiopathic constipation symptoms during the last 12 months.“The findings of this year’s report illustrate a need for more meaningful health care provider visits to help improve clinical outcomes,” Robert Spurr, president of Salix, said in a company press release. “As many as 3.5 million annual health care provider visits for IBS take place in the U.S. each year, and it is our hope that thisRead More